Category:Experimental cancer drugs
Help
Category:Experimental cancer drugs
Jump to navigation
Jump to search
Wikimedia Commons has media related to Experimental cancer drugs. |
Pages in category "Experimental cancer drugs"
The following 200 pages are in this category, out of approximately 235 total. This list may not reflect recent changes (learn more).
A
- Abagovomab
- Abexinostat
- Abituzumab
- Acridine carboxamide
- Adecatumumab
- Adegramotide
- ADH-1
- Adozelesin
- Afimoxifene
- AI-10-49
- Alacizumab pegol
- Aldoxorubicin
- Alkyl-lysophospholipids
- Allovectin-7
- Alvocidib
- Alpha-Amanitin
- Amatuximab
- AMG319
- 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone
- Amonafide
- ANG1005
- Anti-CD22 immunotoxin
- Apatinib
- Artemisinin
- Ascrinvacumab
- Atiprimod
- Atrasentan
- 8-Azaguanine
B
- Bafetinib
- Bavituximab
- Bemcentinib
- O6-Benzylguanine
- BI811283
- 5N-Bicalutamide
- Birabresib
- Bivatuzumab mertansine
- Brigatinib
- Brivanib alaninate
- Bropirimine
- Brostallicin
- Bryostatin
- Buparlisib
C
- Camidanlumab tesirine
- Canertinib
- Cantuzumab mertansine
- Cediranib
- Chlorotoxin
- Cilengitide
- Cixutumumab
- Cobimetinib
- Combretastatin A-4
- Combretastatin A-4 phosphate
- CRLX101
- Cryptolepine
D
- Dacomitinib
- Dactolisib
- Darolutamide
- Demcizumab
- Depatuxizumab mafodotin
- DHA-paclitaxel
- 6-Diazo-5-oxo-L-norleucine
- Dichloroacetic acid
- Dinaciclib
- Discodermolide
- Duligotuzumab
- Duocarmycin
- Durvalumab
- Dusigitumab
- Duvelisib
E
- Eflapegrastim
- EM-5854
- Enfortumab vedotin
- Enoticumab
- Ensituximab
- Entolimod
- Epacadostat
- Erbulozole
- Erdafitinib
- ERX-11
- Ethynylandrostanediol
- Evofosfamide
F
- Fenretinide
- Ferruginol
- Filanesib
- Fluoromedroxyprogesterone acetate
- Forodesine
- Futuximab
G
- Galunisertib
- Gandotinib
- Gedatolisib
- Gilteritinib
- Glasdegib
- Glembatumumab vedotin
- Glesatinib
- Glufosfamide
- GVAX
H
- HAMLET (protein complex)
I
- Ibrutinib
- Icrucumab
- Imalumab
- Imexon
- IMM-101
- IMP321
- Indolocarbazole
- Intetumumab
- Ipatasertib
- Iratumumab
- Irofulven
- Irosustat
- Isatuximab
- Istiratumab
- Ivosidenib
J
- JQ1
L
- Laniquidar
- Larotrectinib
- Lexatumumab
- Lilotomab
- Linsitinib
- Loncastuximab tesirine
- Lorlatinib
- Lorvotuzumab mertansine
- Luminespib
M
- Mafosfamide
- Mapatumumab
- Margetuximab
- Marimastat
- Maytansinoid
- Melflufen
- Merestinib
- Mertansine
- Metapristone
- Milatuzumab
- Mitumomab
- MK-2206
- Momelotinib
N
- NAMI-A
- Navitoclax
- Neocarzinostatin
- Nesvacumab
- NK012
O
- Obatoclax
- Oblimersen
- Ofranergene obadenovec
- Ombrabulin
- Onapristone
- Ontuxizumab
- ONX-0801
- Oprozomib
- Oregovomab
- Osimertinib
- OX1001
P
- PAC-1
- Pacritinib
- Palytoxin
- Patritumab
- Pembrolizumab
- Pexidartinib
- PF-06647020
- Phosphoinositide 3-kinase inhibitor
- Plinabulin
- Plitidepsin
- Polmacoxib
- Poziotinib
- Prexasertib
- Prinomastat
- Pritumumab
- Proxalutamide
Q
- Quisinostat
R
- Radium-223
- Radretumab
- Ralimetinib
- Rebeccamycin
- Relugolix
- Reolysin
- Rigosertib
- Rindopepimut
- RO4929097
- Robatumumab
- Rovalpituzumab tesirine
- Ruthenium anti-cancer drugs
S
- Sacituzumab govitecan
- Salinosporamide A
- Sapacitabine
- Sapanisertib
- Saracatinib
- Saridegib
- Selumetinib
- Seribantumab
- Seviteronel
- Sitravatinib
- Solitomab
- Sonidegib
- Sparsomycin
- Sturamustine
- Sulforaphane
- Swainsonine
T
- Talazoparib
- Tanespimycin
- Tarextumab
- Tariquidar
Categories:
- Experimental cancer treatments
- Experimental drugs
- Antineoplastic drugs
- Chemotherapy
(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.016","walltime":"0.027","ppvisitednodes":"value":53,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":1793,"limit":2097152,"templateargumentsize":"value":135,"limit":2097152,"expansiondepth":"value":8,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":0,"limit":5000000,"entityaccesscount":"value":0,"limit":400,"timingprofile":["100.00% 22.364 1 Template:Commons","100.00% 22.364 1 -total"," 91.30% 20.417 1 Template:Sister_project"," 78.39% 17.531 1 Template:Side_box"],"scribunto":"limitreport-timeusage":"value":"0.004","limit":"10.000","limitreport-memusage":"value":548280,"limit":52428800,"cachereport":"origin":"mw1328","timestamp":"20181012192556","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":112,"wgHostname":"mw1274"););